Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2016 Apr 28;374(17):1687-8.
doi: 10.1056/NEJMc1601160.

Sofosbuvir and Velpatasvir for Patients with HCV Infection

Graham R Foster, Alessandra Mangia, Mark Sulkowski
Comment

Sofosbuvir and Velpatasvir for Patients with HCV Infection

Graham R Foster et al. N Engl J Med. .
No abstract available

PubMed Disclaimer

Comment on

  • Sofosbuvir and Velpatasvir for HCV Genotype 2 and 3 Infection.
    Foster GR, Afdhal N, Roberts SK, Bräu N, Gane EJ, Pianko S, Lawitz E, Thompson A, Shiffman ML, Cooper C, Towner WJ, Conway B, Ruane P, Bourlière M, Asselah T, Berg T, Zeuzem S, Rosenberg W, Agarwal K, Stedman CA, Mo H, Dvory-Sobol H, Han L, Wang J, McNally J, Osinusi A, Brainard DM, McHutchison JG, Mazzotta F, Tran TT, Gordon SC, Patel K, Reau N, Mangia A, Sulkowski M; ASTRAL-2 Investigators; ASTRAL-3 Investigators. Foster GR, et al. N Engl J Med. 2015 Dec 31;373(27):2608-17. doi: 10.1056/NEJMoa1512612. Epub 2015 Nov 17. N Engl J Med. 2015. PMID: 26575258 Clinical Trial.
  • Sofosbuvir and Velpatasvir for Patients with HCV Infection.
    Assy N, Barhoum M. Assy N, et al. N Engl J Med. 2016 Apr 28;374(17):1687. doi: 10.1056/NEJMc1601160. N Engl J Med. 2016. PMID: 27119243 No abstract available.

LinkOut - more resources